Impact News +++ First Phosphate Corp.: First Phosphate Announces Uplisting of American Depositary Receipt (ADR) to Nasdaq... (Newsfile) +++ FIRST PHOSPHATE Aktie +4,02%

DENTSPLY Aktie

>DENTSPLY Aktienkurs

10.615 EUR -7.3% (TradegateBSX)

Ask: 10.505 EUR / 540 Stück

Bid: 10.47 EUR / 540 Stück

Tagesumsatz: 6827 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

DENTSPLY Aktie über LYNX handeln

Intraday

1 Jahr

>DENTSPLY Performance

1 Woche: -10,7%

1 Monat: -1,0%

3 Monate: +12,9%

6 Monate: -8,1%

1 Jahr: -6,8%

laufendes Jahr: +10,7%

>DENTSPLY Aktie

Profil:

Dentsply Sirona Inc. develops, manufactures, and markets professional dental products and technologies worldwide. It specializes in dental equipment supported by cloud-enabled solutions, alongside dental consumables and healthcare products for urolog..
>Volltext..

Insiderhandel:

>DENTSPLY Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>DENTSPLY Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Magen-Darm-Erkrankungen & -behandlung, Zahnmedizin/ zahnmedizinische Behandlungen

>DENTSPLY Chart & Kurs - NASDAQ

>DENTSPLY News

07.08.26 - 23:36

Wellspect HealthCare Establishes Strategic Advisory Board and Appoints Paul Moraviec and Michael Frazzette (Cision)

New Strategic Advisory Board supports Wellspect HealthCare's next phase of growth, with external advisors bringing extensive experience in global MedTech, urology, commercial growth and healthcare leadership. [Mike Frazzette_Paul Moraviec.jpg] Mölndal, Sweden – August 07, 2026 – Wellspect HealthCare, a subsidiary of Dentsply Sirona and a rapidly expanding global provider of innovative medical devices dedicated to improving the quality of life for individuals with bladder and bowel dysfunction, today announced the appointment of Paul Moraviec and Michael (Mike) Frazzette as external...

07.08.26 - 22:24

Wellspect HealthCare Establishes Strategic Advisory Board and Appoints Paul Moraviec and Michael Frazzette (Cision)

07.08.26 - 22:00	XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales (Zacks)
	DENTSPLY SIRONA's Q2 sales fall 4.1% as dental weakness offsets Wellspect growth, while margins improve and 2026 guidance is maintained....

07.08.26 - 17:36

Wellspect HealthCare Establishes Strategic Advisory Board and Appoints Paul Moraviec and Michael Frazzette (Cision)

New Strategic Advisory Board supports Wellspect HealthCare's next phase of growth, with external advisors bringing extensive experience in global MedTech, urology, commercial growth and healthcare leadership. Mölndal, Sweden – August 07, 2026 – Wellspect HealthCare, a subsidiary of Dentsply Sirona and a rapidly expanding global provider of innovative medical devices dedicated to improving the quality of life for individuals with bladder and bowel dysfunction, today announced the appointment of Paul Moraviec and Michael (Mike) Frazzette as external advisors to its Strategic Advisory Board....

07.08.26 - 16:45	Here′s What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings (Zacks)
	The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....

07.08.26 - 02:57	Dentsply Sirona maintains 2026 outlook of $3.5B-$3.6B sales and $1.40-$1.50 adjusted EPS while ramping return-to-growth investments (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.26 - 01:00	Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates (Zacks)
	Dentsply (XRAY) delivered earnings and revenue surprises of +44.44% and +1.60%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?...

07.08.26 - 00:06	Earnings Call: DENTSPLY Sirona übertrifft Umsatzprognose für Q2 2026, Aktie fällt trotzdem (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

06.08.26 - 23:06	Dentsply Sirona Non-GAAP EPS of $0.52 beats by $0.17, revenue of $898M beats by $8.16M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.08.26 - 19:45	DENTSPLY SIRONA to Post Q2 Earnings: What′s in Store for the Stock? (Zacks)
	XRAY's Q2 results are likely to reflect transformation investments, dealer inventory cuts and weak implants, while Wellspect growth offers support....

29.07.26 - 15:15	Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
	Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the......

28.07.26 - 14:33	Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship (GlobeNewswire EN)
	Medline Sinclair to Offer Dentsply Sirona's Full Technology Portfolio Across Canada...

21.07.26 - 22:18

Dentsply Sirona to Host Second Quarter Conference Call on August 6th (GlobeNewswire EN)

CHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to review its second quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call....

01.07.26 - 23:03

PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry (GlobeNewswire EN)

This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients. This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients....

19.06.26 - 03:01	Insiderhandel: Aufsichtsrat kauft Aktien von Dentsply Sirona im Wert von 101400 USD (Insiderkauf)
	Mazelsky, Jonathan Jay - Aufsichtsrat - Tag der Transaktion: 2026-06-12...

17.06.26 - 03:01	Insiderhandel: Aufsichtsrat kauft Aktien von Dentsply Sirona im Wert von 64902 USD (Insiderkauf)
	Hosein, Clyde - Aufsichtsrat - Tag der Transaktion: 2026-06-15...

16.06.26 - 03:01	Insiderhandel: Aufsichtsrat kauft Aktien von Dentsply Sirona im Wert von 99692 USD (Insiderkauf)
	Holden, Betsy D. - Aufsichtsrat - Tag der Transaktion: 2026-06-11...

16.06.26 - 03:01	Insiderhandel: Aufsichtsrat kauft Aktien von Dentsply Sirona im Wert von 150005 USD (Insiderkauf)
	Barber, Michael J. - Aufsichtsrat - Tag der Transaktion: 2026-06-11...

16.06.26 - 03:01	Insiderhandel: Aufsichtsrat kauft Aktien von Dentsply Sirona im Wert von 101200 USD (Insiderkauf)
	Mckeon, Brian P. - Aufsichtsrat - Tag der Transaktion: 2026-06-12...

16.06.26 - 03:01	Insiderhandel: Aufsichtsrat kauft Aktien von Dentsply Sirona im Wert von 100000 USD (Insiderkauf)
	Gladden, Brian T. - Aufsichtsrat - Tag der Transaktion: 2026-06-15...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Was sein wird - wird sein. - Sprichwort Indien

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram